We demonstrate high efficiency electrophosphorescent devices doped by bis(2-phenyl-benzoimidazole) iridium (III) acetylacetonate [Ir(ppi)2acac] with active hydrogen. At 100 mA/cm2 2 wt % Ir(ppi)2acac doped device offers an external quantum efficiency (ηext) of 5.1% and an efficiency roll-off of 28.2%, which decreases for 33.5% and 39.1% compared with that of 2 and 6 wt % fac-tris(2-phenylpyridine) iridium (III) [fac-Ir(ppy)3] doped reference devices, respectively. 7 wt % Ir(ppi)2acac doped device behaves a maximum ηext of 13.4% and a ηext of 8.0% at a luminance of 10 000 cd/m2. Both the ηext are higher than that of the reference device. The improvement in electroluminescent performance was assumed to be the very short triplet lifetime (3.74 ns) induced by the active hydrogen atom.
No takes yet. Share an insight, caveat, or question.
Han et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: